Tardive Dyskinesia Induced by Long‐Acting Injectable Paliperidone Palmitate Once Every 3 Months in a Patient With Schizophrenia: A Case Report and Literature Review
Jianmiao Ge, Jing Li, Ruiting Ma, Lijun Tong, Qijing Bo, Zhiyang Zhang · 2026
Read Tardive Dyskinesia Induced by Long‐Acting Injectable Paliperidone Palmitate Once Every 3 Months in a Patient With Schizophrenia: A Case Report and Literature Review by Jianmiao Ge, Jing Li, Ruiting Ma, Lijun Tong, Qijing Bo, Zhiyang Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13390019.txt.
Description
Jianmiao Ge and co-authors report, in 2026, a case of tardive dyskinesia linked to a long-acting antipsychotic injection given once every three months. The patient, who has schizophrenia, developed the involuntary movement disorder during treatment with paliperidone palmitate.
Unlike daily tablets, a long-acting injection cannot be quickly cleared from the body once movement problems appear, which creates a hard management problem. The authors review past literature and advise regular movement checks, prompt stopping of the long-acting drug, switching to a lower-risk antipsychotic, and supportive care once signs emerge. Psychiatrists gain a concrete warning that convenience in relapse prevention must be balanced with scheduled screening for late movement effects.
Catalog record
| CREATOR | Jianmiao Ge, Jing Li, Ruiting Ma, Lijun Tong, Qijing Bo, Zhiyang Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23115 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |